GlassScriptPhysician profile
Michael J Loguidice
NPI 1134564891
$28,609.86
in general payments reported to CMS, 2019-2025
19 companies · $13K in 2025
The $13K reported for 2025 was more than what 84% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,420 · 2020: $774 · 2021: $824 · 2022: $1,942 · 2023: $7,064 · 2024: $2,853 · 2025: $13K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $8,760 · Food and Beverage: $8,088 · Consulting Fee: $5,400 · Education: $402.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $8,760.37 |
| Food and Beverage | $8,087.71 |
| Consulting Fee | $5,400.00 |
| Education | $401.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $17,552.30 | 2019-2025 | Tacticath Ablation Catheter, Sensor Enabled, Aveir, Ensite |
| Boston Scientific Corporation | $5,619.75 | 2019-2025 | Farapulse, General - Therapies, Emblem Mri S-Icd |
| Medtronic, INC. | $1,829.36 | 2021-2025 | Evera Mri Xt Dr Surescan, Micra, Aurora Ev-Icd Mri Surescan |
| Medtronic Vascular, INC. | $1,682.45 | 2019-2020 | |
| Elutia, INC. | $476.11 | 2022-2024 | Ecm Patch,Pouch |
| Atricure, INC. | $441.28 | 2023-2025 | Epi-Sense Guided Coagulation System With Visitrax, Atriclip Laa Exclusion System |
| Pfizer INC. | $412.48 | 2021-2025 | |
| Biosense Webster, INC. | $148.64 | 2021 | |
| Cardiva Medical, INC. | $144.52 | 2022-2023 | Cardiva Vascade 6/7f Vcs, Cardiva Vascade Mvp Vvcs 6-12f |
| Janssen Pharmaceuticals, INC | $90.72 | 2022-2024 | Xarelto |
| Actelion Pharmaceuticals US, INC. | $38.92 | 2023 | Uptravi |
| Merck Sharp & Dohme LLC | $37.44 | 2022-2023 | Verquvo |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $36.81 | 2023 | Lifevest |
| Abiomed | $21.37 | 2024 | Impella |
| Kestra Medical Technology Services, INC. | $18.47 | 2025 | Assure Wcd |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $16.69 | 2024 | Ozempic, Rybelsus |
| E.R. Squibb & Sons, L.L.C. | $15.36 | 2024 | Camzyos |
| Astrazeneca Pharmaceuticals LP | $13.97 | 2024 | Farxiga |
| Novartis Pharmaceuticals Corporation | $13.22 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Loguidice listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.